Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc COMMON STOCK | 1,047,557 | 1,047,557 | 0 | $68.98M | $86.00M | 74.71% | +$17.02M |
| Kymera Therapeutics, Inc.(KYMR) | 457,059 | 457,059 | 0 | $19.95M | $25.86M | 22.47% | +$5.92M |
| Seer, Inc.CL A(SEER) | 816,375 | 816,375 | 0 | $1.75M | $1.80M | 1.57% | +$57.1K |
| Xilio Therapeutics, Inc.(XLO) | 667,742 | 667,742 | 0 | $454.0K | $595.6K | 0.52% | +$141.6K |
| Rallybio Corporation(RLYB) | 754,678 | 754,678 | 0 | $255.1K | $377.3K | 0.33% | +$122.3K |
| Rapt Therapeutics Inc | 12,437 | 12,437 | 0 | $99.5K | $320.8K | 0.28% | +$221.3K |
| Sutro Biopharma, Inc.(STRO) | 175,000 | 175,000 | 0 | $124.9K | $153.1K | 0.13% | +$28.2K |
| Carisma Therapeutics Inc | 718,332 | 0 | -718,332 | $281.3K | $0 | — | -$281.3K |